Embecta securities fraud class action

Multiple law firms, including Glancy Prongay & Murray LLP and the Law Offices of Howard G. Smith, have filed securities fraud class action lawsuits against Embecta Corp. (Nasdaq: EMBC) on behalf of investors who purchased Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuits allege that Embecta made materially false and misleading statements regarding its business and prospects, failing to disclose that its guidance was unattainable and that segment weakness, particularly in the U.S. pen needle market, would disrupt revenue. On May 5, 2026, Embecta reported a 14% revenue decline and lowered guidance, causing its stock price to fall 57.8% to $3.90 per share. The lead plaintiff deadline is August 17, 2026.